Skip to content

Building Resiliency in Patients Admitted to the Neuroscience Intensive Care Unit and Their Caregivers

Recovering Together: Building Resiliency in Dyads of Patients Admitted to the Neuroscience Intensive Care Unit (NICU) and Their Caregivers

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03694678
Enrollment
126
Registered
2018-10-03
Start date
2019-01-01
Completion date
2020-10-11
Last updated
2025-05-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Brain Injuries

Keywords

Psychiatry, Dyads, Patients, Caregivers, Psychosocial

Brief summary

The investigators will compare a dyadic intervention (Recovering Together) with an attention placebo educational control in dyads of patients with acute neurological illnesses and their caregivers at risk for chronic emotional distress. The primary aim of this study is to determine the feasibility, credibility, and satisfaction with Recovering Together. The second aim is to show proof of concept for sustained improvement in emotional distress, post traumatic stress (PTS), resiliency and interpersonal communication outcomes in patients and caregivers.

Detailed description

The investigators aim to improve the care of patients (pts) admitted to the Neuroscience Intensive Care Unit (NICU) and their family caregivers (cgs) by conducting a pilot feasibility randomized controlled trial (RCT; N=80 dyads; 60 completers) of the dyadic resiliency program (Recovering Together) to prevent chronic emotional distress in both pts and their cgs. Eligible dyads include adult, English speaking pts with acute neurological injury (ANI) admitted to the NICU, cleared medically and cognitively for participation by the nursing team, and their primary cgs. Dyads who are randomly assigned to Recovering Together will receive 6 manualized sessions (2 in person at hospitalization and 4 through live video after discharge, to reduce burden and facilitate access to care) led by a clinical psychologist. Dyads who are randomly assigned to the attention placebo educational control condition will receive 6 manualized sessions (2 in person and 4 through live video with a clinical psychologist), modeled after the Recovering Together program that will control for the dose of the intervention and support from therapist. Dyads will complete assessment surveys before, after the intervention and 3 months later. Clinical data on demographics, diagnosis, ANI severity, and any medical complications will be extracted from electronic health records.

Interventions

The intervention will teach resiliency skills (mindfulness, coping, interpersonal communication, etc) within 2 in person sessions at hospitalization and 4 live video sessions after discharge. Both patient and caregiver will participate in all sessions

Sponsors

Massachusetts General Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Male and female patients, 18 years or older * English fluency and literacy * Access to high speed internet for video sessions * Patient with an informal cg (family or friend who provides unpaid care) available and willing to participate * Hospitalized with an acute brain injury within 1-2 days when first approached, OR the primary caregiver of a patient currently admitted with an acute brain injury * Either patient or caregiver within the dyads screens in for depression, anxiety, and/or PTSD

Exclusion criteria

* Permanent or severe cognitive impairment severe enough to impede participation - This will be determined by nurses through an assessment conducted as part of usual care (MMSE). * Dyads where the patient is anticipated to die or to never be able to participate due to medical sequelae.

Design outcomes

Primary

MeasureTime frameDescription
Client Satisfaction Questionnairepost intervention (6 weeks after baseline)This measure will assess participants' satisfaction with participation in the study. The score range is 0-12. Higher scores indicate greater satisfaction.
Feasibility of Recruitment (Ability to Recruit Dyads)BaselineFeasibility of recruitment will be determined by reporting number of dyads who meet study criteria who enrolled
Feasibility of Intervention Delivery (Ability to Deliver Intervention to Dyads)Feasibility of program delivery will be measured at 6 weeksWe will report number of sessions completed by each dyad. We will report any technical difficulties with live video delivery
Credibility and Expectancy QuestionnaireBaselineThis measure will assess participants' belief that the intervention (or control) will be helpful. The score range is 3-27. Higher scores mean higher perception of credibility or expectancy.

Secondary

MeasureTime frameDescription
Dyadic Relationship ScaleBaseline, post treatment, 3-month follow-upThe Dyadic Relationship Scale (DRS) has 2 sub scales that assess dyadic strains and dyadic positive interaction. Scales on each sub scale range from 1 to 4, with higher scores indicating great severity of the relevant construct.
Measures of Coping Style Part Abaseline to posttest to 3 months follow upThe MOCS-A measures various coping strategies such as relaxation or adaptive thinking. Scores range from 0 to 52, and higher scores indicate greater self-perceived proficiency with these skills.
Cognitive and Affective Mindfulness Scale Revisedbaseline to post test to 3 months follow upMeasures mindfulness skills used in daily life. The scale ranges from 12 to 48 with higher scores indicating higher mindfulness.
Hospital Anxiety and Depression Scalebaseline to posttest to 3 months follow upMeasures symptoms of emotional distress and estimates diagnoses. The scale has 14 items, 7 assess anxiety and 7 depression. Scores range from 0-21 on each subscale, wtih higher scores indicating more symptoms. Scores greater than 8 indicate clinically significant symptoms.
Post Traumatic Checklistbaseline to posttest to 3 months follow upThe PTSD CheckList - Civilian Version measures symptoms of post traumatic stress and determines diagnoses. Scores range from 17-85. Higher scores indicate more severe stress.

Countries

United States

Participant flow

Participants by arm

ArmCount
Recovering Together: Patients
Participants who are randomly assigned to the Recovering Together program received any usual clinic care as determined by their clinicians. Additionally, participants were invited to participate in 6 30-minute skills sessions. All sessions included both pt and cg. A clinical psychologist delivered the majority of sessions while the PI delivered at least 10% of the sessions. The main intervention goal was to provide dyads with resiliency and interpersonal communication skills necessary to optimize their recovery and reduce emotional distress and PTS. Recovering Together: The intervention taught resiliency skills (mindfulness, coping, interpersonal communication, etc) within 2 in person sessions at hospitalization and 4 live video sessions after discharge. Both patient and caregiver participated in all sessions
29
Recovering Together: Caregivers
Participants who are randomly assigned to the Recovering Together program received any usual clinic care as determined by their clinicians. Additionally, participants were invited to participate in 6 30-minute skills sessions. All sessions included both pt and cg. A clinical psychologist delivered the majority of sessions while the PI delivered at least 10% of the sessions. The main intervention goal was to provide dyads with resiliency and interpersonal communication skills necessary to optimize their recovery and reduce emotional distress and PTS. Recovering Together: The intervention taught resiliency skills (mindfulness, coping, interpersonal communication, etc) within 2 in person sessions at hospitalization and 4 live video sessions after discharge. Both patient and caregiver participated in all sessions
29
Health Education: Patients
Participants randomly assigned to the control condition received an educational program that mimics the dose and duration of the Recovering Together Program but without teaching any of the resiliency or interpersonal communication skills that were hypothesized to be responsible for improvement in emotional distress. The control entailed 2 in-person dyadic visits in the NICU and 4 dyadic virtual visits after discharge. All sessions included both pt and cg.
29
Health Education: Caregivers
Participants randomly assigned to the control condition received an educational program that mimics the dose and duration of the Recovering Together Program but without teaching any of the resiliency or interpersonal communication skills that were hypothesized to be responsible for improvement in emotional distress. The control entailed 2 in-person dyadic visits in the NICU and 4 dyadic virtual visits after discharge. All sessions included both pt and cg.
29
Total116

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyLost to Follow-up23
Overall StudyWithdrawal by Subject20

Baseline characteristics

CharacteristicTotalHealth Education: CaregiversHealth Education: PatientsRecovering Together: CaregiversRecovering Together: Patients
Age, Continuous50.9 Years
STANDARD_DEVIATION 15.5
52.1 Years
STANDARD_DEVIATION 14.9
50.1 Years
STANDARD_DEVIATION 16.4
52.4 Years
STANDARD_DEVIATION 14.3
49.3 Years
STANDARD_DEVIATION 16.7
Employment status
Employed full-time
62 Participants18 Participants12 Participants14 Participants18 Participants
Employment status
Employed part-time
7 Participants2 Participants1 Participants3 Participants1 Participants
Employment status
Full-time or part-time student
4 Participants1 Participants1 Participants1 Participants1 Participants
Employment status
Homemaker
5 Participants2 Participants1 Participants2 Participants0 Participants
Employment status
Other
15 Participants2 Participants6 Participants3 Participants4 Participants
Employment status
Retired
23 Participants4 Participants8 Participants6 Participants5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
3 Participants1 Participants1 Participants0 Participants1 Participants
Race (NIH/OMB)
Black or African American
11 Participants3 Participants2 Participants4 Participants2 Participants
Race (NIH/OMB)
More than one race
3 Participants1 Participants1 Participants0 Participants1 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
5 Participants4 Participants1 Participants0 Participants0 Participants
Race (NIH/OMB)
White
94 Participants20 Participants24 Participants25 Participants25 Participants
Sex: Female, Male
Female
60 Participants17 Participants12 Participants22 Participants9 Participants
Sex: Female, Male
Male
56 Participants12 Participants17 Participants7 Participants20 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
deaths
Total, all-cause mortality
0 / 300 / 300 / 310 / 31
other
Total, other adverse events
0 / 300 / 300 / 310 / 31
serious
Total, serious adverse events
0 / 300 / 300 / 310 / 31

Outcome results

Primary

Client Satisfaction Questionnaire

This measure will assess participants' satisfaction with participation in the study. The score range is 0-12. Higher scores indicate greater satisfaction.

Time frame: post intervention (6 weeks after baseline)

Population: Score on Client Satisfaction Questionnaire

ArmMeasureValue (MEAN)Dispersion
Eligible ParticipantsClient Satisfaction Questionnaire10.65 score on a scaleStandard Deviation 1.18
Health EducationClient Satisfaction Questionnaire9.87 score on a scaleStandard Deviation 2.7
Primary

Credibility and Expectancy Questionnaire

This measure will assess participants' belief that the intervention (or control) will be helpful. The score range is 3-27. Higher scores mean higher perception of credibility or expectancy.

Time frame: Baseline

Population: Score on Credibility and Expectancy Questionnaire

ArmMeasureGroupValue (MEAN)Dispersion
Eligible ParticipantsCredibility and Expectancy QuestionnaireCredibility and Expectancy Questionnaire; credibility subscale22.0 score on a scaleStandard Deviation 4.4
Eligible ParticipantsCredibility and Expectancy QuestionnaireCredibility and Expectancy Questionnaire; expectancy subscale19.0 score on a scaleStandard Deviation 5.2
Health EducationCredibility and Expectancy QuestionnaireCredibility and Expectancy Questionnaire; credibility subscale20.3 score on a scaleStandard Deviation 4.8
Health EducationCredibility and Expectancy QuestionnaireCredibility and Expectancy Questionnaire; expectancy subscale19.5 score on a scaleStandard Deviation 5.6
Primary

Feasibility of Intervention Delivery (Ability to Deliver Intervention to Dyads)

We will report number of sessions completed by each dyad. We will report any technical difficulties with live video delivery

Time frame: Feasibility of program delivery will be measured at 6 weeks

Population: Number of dyads who started RT who had at least 1 member complete post treatment assessment

ArmMeasureGroupValue (NUMBER)
Eligible ParticipantsFeasibility of Intervention Delivery (Ability to Deliver Intervention to Dyads)Number of dyads who started RT who had at least 1 member complete post treatment assessment29 dyads
Eligible ParticipantsFeasibility of Intervention Delivery (Ability to Deliver Intervention to Dyads)Number of dyads who started RT who had neither member complete post treatment assessment1 dyads
Health EducationFeasibility of Intervention Delivery (Ability to Deliver Intervention to Dyads)Number of dyads who started RT who had neither member complete post treatment assessment0 dyads
Health EducationFeasibility of Intervention Delivery (Ability to Deliver Intervention to Dyads)Number of dyads who started RT who had at least 1 member complete post treatment assessment31 dyads
Primary

Feasibility of Recruitment (Ability to Recruit Dyads)

Feasibility of recruitment will be determined by reporting number of dyads who meet study criteria who enrolled

Time frame: Baseline

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Eligible ParticipantsFeasibility of Recruitment (Ability to Recruit Dyads)Participants who enrolled and randomized122 Participants
Eligible ParticipantsFeasibility of Recruitment (Ability to Recruit Dyads)Participants who declined40 Participants
Eligible ParticipantsFeasibility of Recruitment (Ability to Recruit Dyads)Participants who enrolled and did not randomize4 Participants
Secondary

Cognitive and Affective Mindfulness Scale Revised

Measures mindfulness skills used in daily life. The scale ranges from 12 to 48 with higher scores indicating higher mindfulness.

Time frame: baseline to post test to 3 months follow up

ArmMeasureGroupValue (MEAN)Dispersion
Eligible ParticipantsCognitive and Affective Mindfulness Scale Revised3-month follow-up35.5 score on a scaleStandard Deviation 7.9
Eligible ParticipantsCognitive and Affective Mindfulness Scale RevisedPosttreatment36.7 score on a scaleStandard Deviation 7.7
Eligible ParticipantsCognitive and Affective Mindfulness Scale RevisedBaseline34.2 score on a scaleStandard Deviation 7
Health EducationCognitive and Affective Mindfulness Scale Revised3-month follow-up36.3 score on a scaleStandard Deviation 7.5
Health EducationCognitive and Affective Mindfulness Scale RevisedBaseline34.6 score on a scaleStandard Deviation 5.8
Health EducationCognitive and Affective Mindfulness Scale RevisedPosttreatment36.3 score on a scaleStandard Deviation 6.5
Health Education: PatientsCognitive and Affective Mindfulness Scale RevisedPosttreatment35.0 score on a scaleStandard Deviation 10.7
Health Education: PatientsCognitive and Affective Mindfulness Scale Revised3-month follow-up32.3 score on a scaleStandard Deviation 9
Health Education: PatientsCognitive and Affective Mindfulness Scale RevisedBaseline35.1 score on a scaleStandard Deviation 7.8
Health Education: CaregiversCognitive and Affective Mindfulness Scale RevisedPosttreatment36.7 score on a scaleStandard Deviation 8.5
Health Education: CaregiversCognitive and Affective Mindfulness Scale Revised3-month follow-up33.3 score on a scaleStandard Deviation 9.4
Health Education: CaregiversCognitive and Affective Mindfulness Scale RevisedBaseline36.4 score on a scaleStandard Deviation 7.6
Secondary

Dyadic Relationship Scale

The Dyadic Relationship Scale (DRS) has 2 sub scales that assess dyadic strains and dyadic positive interaction. Scales on each sub scale range from 1 to 4, with higher scores indicating great severity of the relevant construct.

Time frame: Baseline, post treatment, 3-month follow-up

ArmMeasureGroupValue (MEAN)Dispersion
Eligible ParticipantsDyadic Relationship ScalePositive interactions: posttreatment3.4 score on a scaleStandard Deviation 0.6
Eligible ParticipantsDyadic Relationship ScaleDyadic strain: posttreatment1.6 score on a scaleStandard Deviation 0.6
Eligible ParticipantsDyadic Relationship ScalePositive interactions: 3-month follow-up3.2 score on a scaleStandard Deviation 0.6
Eligible ParticipantsDyadic Relationship ScaleDyadic strain: 3-month follow-up1.9 score on a scaleStandard Deviation 0.8
Eligible ParticipantsDyadic Relationship ScalePositive interactions: baseline3.1 score on a scaleStandard Deviation 0.5
Eligible ParticipantsDyadic Relationship ScaleDyadic strain: baseline2.0 score on a scaleStandard Deviation 0.8
Health EducationDyadic Relationship ScaleDyadic strain: 3-month follow-up2.2 score on a scaleStandard Deviation 0.8
Health EducationDyadic Relationship ScalePositive interactions: 3-month follow-up3.2 score on a scaleStandard Deviation 0.6
Health EducationDyadic Relationship ScalePositive interactions: baseline3.0 score on a scaleStandard Deviation 0.5
Health EducationDyadic Relationship ScalePositive interactions: posttreatment3.3 score on a scaleStandard Deviation 0.5
Health EducationDyadic Relationship ScaleDyadic strain: posttreatment2.01 score on a scaleStandard Deviation 0.8
Health EducationDyadic Relationship ScaleDyadic strain: baseline2.0 score on a scaleStandard Deviation 0.7
Health Education: PatientsDyadic Relationship ScaleDyadic strain: posttreatment2.0 score on a scaleStandard Deviation 0.9
Health Education: PatientsDyadic Relationship ScalePositive interactions: posttreatment2.97 score on a scaleStandard Deviation 0.77
Health Education: PatientsDyadic Relationship ScalePositive interactions: 3-month follow-up2.82 score on a scaleStandard Deviation 0.67
Health Education: PatientsDyadic Relationship ScalePositive interactions: baseline3.2 score on a scaleStandard Deviation 0.6
Health Education: PatientsDyadic Relationship ScaleDyadic strain: 3-month follow-up2.0 score on a scaleStandard Deviation 0.9
Health Education: PatientsDyadic Relationship ScaleDyadic strain: baseline2.0 score on a scaleStandard Deviation 0.78
Health Education: CaregiversDyadic Relationship ScaleDyadic strain: 3-month follow-up2.2 score on a scaleStandard Deviation 0.8
Health Education: CaregiversDyadic Relationship ScalePositive interactions: posttreatment3.2 score on a scaleStandard Deviation 0.7
Health Education: CaregiversDyadic Relationship ScaleDyadic strain: posttreatment2.1 score on a scaleStandard Deviation 0.9
Health Education: CaregiversDyadic Relationship ScalePositive interactions: 3-month follow-up3.0 score on a scaleStandard Deviation 0.7
Health Education: CaregiversDyadic Relationship ScaleDyadic strain: baseline1.8 score on a scaleStandard Deviation 0.7
Health Education: CaregiversDyadic Relationship ScalePositive interactions: baseline3.3 score on a scaleStandard Deviation 0.4
Secondary

Hospital Anxiety and Depression Scale

Measures symptoms of emotional distress and estimates diagnoses. The scale has 14 items, 7 assess anxiety and 7 depression. Scores range from 0-21 on each subscale, wtih higher scores indicating more symptoms. Scores greater than 8 indicate clinically significant symptoms.

Time frame: baseline to posttest to 3 months follow up

ArmMeasureGroupValue (MEAN)Dispersion
Eligible ParticipantsHospital Anxiety and Depression ScaleBaseline: depression8.7 score on a scaleStandard Deviation 4.2
Eligible ParticipantsHospital Anxiety and Depression ScalePosttreatment: depression4.0 score on a scaleStandard Deviation 4.1
Eligible ParticipantsHospital Anxiety and Depression Scale3-month follow-up: depression3.7 score on a scaleStandard Deviation 3.3
Eligible ParticipantsHospital Anxiety and Depression ScaleBaseline: anxiety11.1 score on a scaleStandard Deviation 4.7
Eligible ParticipantsHospital Anxiety and Depression ScalePosttreatment: anxiety3.3 score on a scaleStandard Deviation 4.1
Eligible ParticipantsHospital Anxiety and Depression Scale3-month follow-up: anxiety4.7 score on a scaleStandard Deviation 4.8
Health EducationHospital Anxiety and Depression ScaleBaseline: depression7.8 score on a scaleStandard Deviation 2.7
Health EducationHospital Anxiety and Depression ScaleBaseline: anxiety13.2 score on a scaleStandard Deviation 3.9
Health EducationHospital Anxiety and Depression Scale3-month follow-up: depression2.42 score on a scaleStandard Deviation 2.58
Health EducationHospital Anxiety and Depression Scale3-month follow-up: anxiety5.3 score on a scaleStandard Deviation 3.8
Health EducationHospital Anxiety and Depression ScalePosttreatment: depression3.28 score on a scaleStandard Deviation 3.37
Health EducationHospital Anxiety and Depression ScalePosttreatment: anxiety6.0 score on a scaleStandard Deviation 3.8
Health Education: PatientsHospital Anxiety and Depression ScalePosttreatment: depression7.2 score on a scaleStandard Deviation 3.7
Health Education: PatientsHospital Anxiety and Depression Scale3-month follow-up: depression7.7 score on a scaleStandard Deviation 5
Health Education: PatientsHospital Anxiety and Depression Scale3-month follow-up: anxiety8.9 score on a scaleStandard Deviation 6
Health Education: PatientsHospital Anxiety and Depression ScaleBaseline: anxiety6.3 score on a scaleStandard Deviation 4
Health Education: PatientsHospital Anxiety and Depression ScaleBaseline: depression7.1 score on a scaleStandard Deviation 4
Health Education: PatientsHospital Anxiety and Depression ScalePosttreatment: anxiety8.5 score on a scaleStandard Deviation 5.2
Health Education: CaregiversHospital Anxiety and Depression Scale3-month follow-up: anxiety9.62 score on a scaleStandard Deviation 5.02
Health Education: CaregiversHospital Anxiety and Depression ScalePosttreatment: anxiety8.1 score on a scaleStandard Deviation 6.1
Health Education: CaregiversHospital Anxiety and Depression ScalePosttreatment: depression6.1 score on a scaleStandard Deviation 5.4
Health Education: CaregiversHospital Anxiety and Depression ScaleBaseline: depression4.8 score on a scaleStandard Deviation 3.8
Health Education: CaregiversHospital Anxiety and Depression ScaleBaseline: anxiety7.0 score on a scaleStandard Deviation 4.7
Health Education: CaregiversHospital Anxiety and Depression Scale3-month follow-up: depression7.27 score on a scaleStandard Deviation 5.28
Secondary

Measures of Coping Style Part A

The MOCS-A measures various coping strategies such as relaxation or adaptive thinking. Scores range from 0 to 52, and higher scores indicate greater self-perceived proficiency with these skills.

Time frame: baseline to posttest to 3 months follow up

ArmMeasureGroupValue (MEAN)Dispersion
Eligible ParticipantsMeasures of Coping Style Part A3-month follow-up2.5 score on a scaleStandard Deviation 0.7
Eligible ParticipantsMeasures of Coping Style Part ABaseline2.2 score on a scaleStandard Deviation 0.8
Eligible ParticipantsMeasures of Coping Style Part APosttest2.7 score on a scaleStandard Deviation 0.8
Health EducationMeasures of Coping Style Part ABaseline2.3 score on a scaleStandard Deviation 0.6
Health EducationMeasures of Coping Style Part A3-month follow-up2.5 score on a scaleStandard Deviation 0.9
Health EducationMeasures of Coping Style Part APosttest2.6 score on a scaleStandard Deviation 1.1
Health Education: PatientsMeasures of Coping Style Part APosttest2.4 score on a scaleStandard Deviation 0.8
Health Education: PatientsMeasures of Coping Style Part ABaseline2.6 score on a scaleStandard Deviation 0.9
Health Education: PatientsMeasures of Coping Style Part A3-month follow-up2.2 score on a scaleStandard Deviation 1
Health Education: CaregiversMeasures of Coping Style Part ABaseline2.5 score on a scaleStandard Deviation 0.9
Health Education: CaregiversMeasures of Coping Style Part A3-month follow-up2.3 score on a scaleStandard Deviation 1
Health Education: CaregiversMeasures of Coping Style Part APosttest2.4 score on a scaleStandard Deviation 1.2
Secondary

Post Traumatic Checklist

The PTSD CheckList - Civilian Version measures symptoms of post traumatic stress and determines diagnoses. Scores range from 17-85. Higher scores indicate more severe stress.

Time frame: baseline to posttest to 3 months follow up

ArmMeasureGroupValue (MEAN)Dispersion
Eligible ParticipantsPost Traumatic ChecklistBaseline41.6 score on a scaleStandard Deviation 12.9
Eligible ParticipantsPost Traumatic Checklist3-month follow-up28.2 score on a scaleStandard Deviation 10.1
Eligible ParticipantsPost Traumatic ChecklistPosttreatment26.4 score on a scaleStandard Deviation 10.8
Health EducationPost Traumatic ChecklistBaseline43.2 score on a scaleStandard Deviation 10.7
Health EducationPost Traumatic Checklist3-month follow-up27.3 score on a scaleStandard Deviation 7.7
Health EducationPost Traumatic ChecklistPosttreatment39.3 score on a scaleStandard Deviation 9.8
Health Education: PatientsPost Traumatic ChecklistPosttreatment34.6 score on a scaleStandard Deviation 12.1
Health Education: PatientsPost Traumatic ChecklistBaseline29.3 score on a scaleStandard Deviation 12.1
Health Education: PatientsPost Traumatic Checklist3-month follow-up41.7 score on a scaleStandard Deviation 16
Health Education: CaregiversPost Traumatic ChecklistBaseline29.4 score on a scaleStandard Deviation 12
Health Education: CaregiversPost Traumatic Checklist3-month follow-up37.7 score on a scaleStandard Deviation 16.1
Health Education: CaregiversPost Traumatic ChecklistPosttreatment35.9 score on a scaleStandard Deviation 16.6

Source: ClinicalTrials.gov · Data processed: Feb 17, 2026